ProPhase Labs, Inc. (PRPH)
0.1507
+0.01
(+9.20%)
USD |
NASDAQ |
Dec 09, 15:42
ProPhase Labs EPS Diluted (Quarterly): -0.1646 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| FONAR Corp. | 0.3368 |
| XWELL, Inc. | -0.2557 |
| Veracyte, Inc. | 0.2401 |
| Insight Molecular Diagnostics, Inc. | -0.3388 |
| Exagen, Inc. | -0.3089 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -6.839M |
| Revenue (Quarterly) | 0.883M |
| Total Expenses (Quarterly) | 7.722M |
| Enterprise Value | 13.65M |
| Gross Profit Margin (Quarterly) | -73.67% |
| Profit Margin (Quarterly) | -774.5% |
| Earnings Yield | -499.7% |
| Normalized Earnings Yield | -489.25 |